TLSA Latest Headlines

Tiziana Life Sciences’ Intranasal Foralumab MS Study Published in Leading Neurology Journal

at www.tipranks.com (Tue, 20-Jan 11:48 AM)

Tiziana Life Sciences Raises $8.8 Million in Oversubscribed Direct Offering to Fund Phase 2 Trials

at www.tipranks.com (Fri, 16-Jan 3:27 PM)

Tiziana Life Sciences prices $8M registered direct offering

at seekingalpha.com (Fri, 16-Jan 8:45 AM)

Tiziana Life Sciences Raises Up to $17.6 Million in Insider-Led Direct Offering to Fund Phase 2 Trials

at www.tipranks.com (Fri, 16-Jan 7:28 AM)